TOP｜ 特許｜ 意匠｜ 商標
商標ウォッチ Twitter
公開日2025-08-06
公報種別公開国際商標公報
国際登録番号1858463
国際登録日2025-04-11
区分第40類(製造・加工),第42類(科学・技術)
商品役務Custom manufacturing of cell culture and cell therapy and gene edited cell therapy apparatus and equipment for others; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies for others; custom manufacture of cellular therapies; information, advice and consultancy in relation to all the aforesaid.,Platform-as-a-service [PaaS] in the field of cell therapy, and cell therapy development; providing temporary use of a web-based platform that offers tools, technologies, processes and data analysis capabilities for researchers and scientists to streamline the development and characterization of cell lines; providing temporary use of a technological platform for the manufacturing of cell-based therapies, including technology, processes, and data analytics capabilities for process optimization and quality control; platform-as-a-service [PaaS] for monitoring patient health; laboratory research in the field of biotechnology; scientific research, design and technological development services in biotechnology, the pharmaceutical and medical industry; scientific research, design and development of scientific cell culture, cell therapy or gene edited cell therapy equipment and apparatus; scientific research, design and development of cell culture, cell therapy or gene edited cell therapy manufacturing equipment, manufacturing systems and manufacturing processes for others; scientific consultation services in the field of biotechnology全 27 件を表示, specifically in relation to cell culture, cell therapy, or gene edited cell therapy manufacturing; providing information with respect to scientific research in the field of stem cells, cell therapy and edited cell gene therapy; initial set-up, configuration, and calibration, of scientific apparatus, machines and equipment used for cell culture, cell therapy and edited cell gene therapy; industrial biotechnology statistical analysis to extract insights from cell line development experiments and data.
基礎出願番号1490211
基礎出願日2023-09-11
基礎出願国BX
出願人Celyntra Therapeutics SA
OCRテキストPULSE
OCRテキスト2PULSE
OCRについて
この商標をJ-PlatPat（特許庁公式サイト）で参照する

関連商標